Register for our free email digests:
Latest From Forticell Bioscience Inc.
The dream of turning stem cell research into mainstream clinical therapies is making significant progress, as a large number of cell-based clinical studies are currently underway - some 2,700 stem cell clinical trials registered with www.clinicaltrials.gov between February 2000 and June 2010. While several companies have launched stem cell products onto the market, it’s the number of products in the pipeline that is starting to capture the attention of observers – including investors – who believe activity in current clinical trials is a telling sign of where the industry is headed.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- South Korea
- Pacific Rim
- Parent & Subsidiaries
- Seegene Inc.
- Senior Management
- Jong-Yoon Chun, PhD, Pres. & CEO
- Contact Info
Phone: (82) 2-2240-4000
91, Ogeum-ro, Songpa-gu
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.